Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07801417Active, not recruiting
Randomised trial of Perioscience Gel in periodontitis (4 arms), sponsored by Al-Azhar University. Primary endpoints: Interleukin-1 at 6 months and Tumor Necrosis Factor-alpha at 6 months. Started Dec 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07801417.